Product
Nivolumab and Relatlimab
Aliases
nivolumab and relatlimab, Opdualag
Name
nivolumab and relatlimab
1 clinical trial
2 drugs
1 indication
Indication
Metastatic Uveal Melanoma in the LiverDrug
RelatlimabClinical trial
A Phase 1/1b, Open-Label Study of the Pressure-Enabled Hepatic Artery Infusion of SD-101, a TLR9 Agonist, Alone or in Combination With Intravenous Checkpoint Blockade in Adults With Metastatic Uveal MelanomaStatus: Active (not recruiting), Estimated PCD: 2024-09-01